Although transcriptomic data is now available from COVID-19 infected patient tissues24,25, our approach generated the list of candidate drugs using gene signatures generated from SARS-CoV-2 infected A549_ACE2 cell lines from dataset GSE14750724. The gene discussed is ACE2; the disease is COVID-19.